Skip to Main Content

Paper Details

Cilengitide in patients with recurrent glioblastoma: the results of NABTC 03-02, a phase II trial with measures of treatment delivery.
J Neurooncol
109
2012
Cilengitide, Patients, blood, cilengitide, cyclic pentapeptide, glioblastoma, glioma, patients, recurrent glioblastoma, tumor, v3 and v5 integrins

Datasets

Release 1.2